[Advance in clinical studies on atherosclerosis].
Atherosclerosis leading to coronary heart disease and cerebrovascular disorders is the most serious cause of death in the industrialized societies. For the last two decades, great advances have been made in understanding the pathogenesis of those disorders by studies based on molecular and cell biology. These findings have been confirmed by several randomized clinical trials. In this article, the current status of treatment and prevention of atherosclerosis will be reviewed and discussed.
Yokode
M
M
Department of Geriatric Medicine, Kyoto University Graduate School of Medicine.
D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D019821:Simvastatin / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D019821:Simvastatin